Nervous System News and Research

Latest Nervous System News and Research

Using stem cells to tackle CNS disorders: an interview with Dr Stefano Pluchino

My laboratory’s long standing interest is the study of the signaling capabilities of stem cells, both under homeostatic conditions

From Beckman Coulter Life Sciences - Flow Cytometry 5 Jan 2016

Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

Researchers from Memphis, Tennessee, have examined intracranial gunshot wounds (GSWs) in children and adolescents, and identified nine clinical, laboratory, and radiological factors that were predictive of these patients' outcomes.

5 Jan 2016

Araim Pharmaceuticals forms new strategic collaboration with Vault Bioventures to market novel peptides

Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.

4 Jan 2016

3-D recordings of nematode brains may help understand how neurons coordinate action and perception

Princeton University researchers have captured among the first recordings of neural activity in nearly the entire brain of a free-moving animal. The three-dimensional recordings could provide scientists with a better understanding of how neurons coordinate action and perception in animals.

31 Dec 2015

UW-led effort aims to develop implantable devices that promote brain plasticity, reanimate paralyzed limbs

In the next decade, people who have suffered a spinal cord injury or stroke could have their mobility improved or even restored through a radically new technology: implantable devices that can send signals between regions of the brain or nervous system that have been disconnected due to injury.

30 Dec 2015

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

Amarantus BioScience Holdings, Inc., a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the US Food and Drug Administration to treat GCMN with Engineered Skin Substitute (ESS).

30 Dec 2015

Researchers identify inherited traits related to sleep, wake and activity cycles

In the first study of its kind, a team of international scientists led by UT Southwestern Medical Center and UCLA researchers have identified a dozen inherited traits related to sleep, wake, and activity cycles that are associated with severe bipolar disorder.

29 Dec 2015

TweetChat on AAN's guideline for diagnosing and treating sports concussions

As the nation expands its conversation about sports concussion this week, the American Academy of Neurology, the world's most trusted authority on concussion, will host a TweetChat at 1 p.m. ET, Monday, December 28, to help educate parents, coaches and athletes about the AAN's guideline for diagnosing and treating sports concussion.

24 Dec 2015

Hepatitis C virus linked to increased risk of developing Parkinson's disease

The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the December 23, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology.

24 Dec 2015

Personalised approach may help identify patients’ response to certain cancer treatments

Many people in Russia know about the Dima Rogachev Centre - particularly those who have faced the challenge of child cancer.

23 Dec 2015

New study reveals why some vestibular schwannomas cause hearing loss

A new study at Massachusetts Eye and Ear showed that in some cases of vestibular schwannoma, a sometimes-lethal tumor often associated with neurofibromatosis 2 (NF2), secretions from the tumor contain toxic molecules that damage the inner ear.

23 Dec 2015

Alexza receives notification letter regarding noncompliance with NASDAQ listing rule

Alexza Pharmaceuticals, Inc. announced today that on December 17, 2015, the Company received a letter from the Nasdaq Staff indicating that the Company had not regained compliance with the $35 million market capitalization requirement for continued listing on The Nasdaq Capital Market by the end of the previously granted compliance period, which expired on December 16, 2015.

23 Dec 2015

Novoron Bioscience receives NIH grant to study novel therapeutic approach for multiple sclerosis

Novoron Bioscience, Inc., a private biotech company dedicated to developing new therapeutics for disorders of the central nervous system, today announced that the company has been awarded a National Institutes of Health grant under the Small Business Innovation Research (SBIR) Program.

22 Dec 2015

Drug that boosts activity in the brain's 'garbage disposal' system may slow Alzheimer's disease

A drug that boosts activity in the brain's "garbage disposal" system can decrease levels of toxic proteins associated with Alzheimer's disease and other neurodegenerative disorders and improve cognition in mice, a new study by neuroscientists at Columbia University Medical Center has found.

22 Dec 2015

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Alexza Pharmaceuticals, Inc. today announced interim results of its Phase 2a study of AZ-002 (Staccato alprazolam) in epilepsy patients. AZ-002 produced a dose-related decrease in mean Standardized Photosensivity Range (SPR), the primary endpoint in the study.

21 Dec 2015

Aquinnah secures $5 million private equity investment from Takeda

Aquinnah Pharmaceuticals announced today that it has received a $5 Million investment from Takeda Pharmaceutical Company, Limited, in it's first private equity financing. The company has assembled a world-class team of drug developers and an exceptional Scientific Advisory Board in the fields of Amyotrophic Lateral Sclerosis (ALS), protein and RNA regulation, and neurodegenerative diseases.

21 Dec 2015

Targeted alpha therapy has potential to reduce HIV-infected cells from central nervous system

Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.

21 Dec 2015

Central thalamus tunes the brain to different states of activity and arousal

Scientists showed that they could alter brain activity of rats and either wake them up or put them in an unconscious state by changing the firing rates of neurons in the central thalamus, a region known to regulate arousal.

18 Dec 2015

New study sheds light on the molecular basis of memory and learning

The brain still harbours many unknowns. Basically, it is assumed that it stores experiences by altering the connections between brain cells. This ability to adapt - which is also called "plasticity" - provides the basis for memory and learning, which is the ability to draw conclusions from memories. On a molecular scale these changes are mediated by modifications of expression of specific genes that as required strengthen or weaken the connections between the brain cells.

18 Dec 2015

Fish oil can help transform fat-storage cells into fat-burning cells

Researchers have found that fish oil transforms fat-storage cells into fat-burning cells, which may reduce weight gain in middle age.

18 Dec 2015

Nervous System News and Research

Latest Nervous System News and Research

Using stem cells to tackle CNS disorders: an interview with Dr Stefano Pluchino

Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

Araim Pharmaceuticals forms new strategic collaboration with Vault Bioventures to market novel peptides

3-D recordings of nematode brains may help understand how neurons coordinate action and perception

UW-led effort aims to develop implantable devices that promote brain plasticity, reanimate paralyzed limbs

Amarantus seeks FDA's Rare Pediatric Disease Designation and ODD to treat GCMN with Engineered Skin Substitute

Researchers identify inherited traits related to sleep, wake and activity cycles

TweetChat on AAN's guideline for diagnosing and treating sports concussions

Hepatitis C virus linked to increased risk of developing Parkinson's disease

Personalised approach may help identify patients’ response to certain cancer treatments

New study reveals why some vestibular schwannomas cause hearing loss

Alexza receives notification letter regarding noncompliance with NASDAQ listing rule

Novoron Bioscience receives NIH grant to study novel therapeutic approach for multiple sclerosis

Drug that boosts activity in the brain's 'garbage disposal' system may slow Alzheimer's disease

Alexza reports interim results from AZ-002 Phase 2a study in epilepsy patients

Aquinnah secures $5 million private equity investment from Takeda

Targeted alpha therapy has potential to reduce HIV-infected cells from central nervous system

Central thalamus tunes the brain to different states of activity and arousal

New study sheds light on the molecular basis of memory and learning

Fish oil can help transform fat-storage cells into fat-burning cells

Everything you need to know about epilepsy eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Nervous System News and Research

Latest Nervous System News and Research

Everything you need to know about epilepsy eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in